staurosporine has been researched along with lbw242 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catley, L; Cools, J; Gilliland, G; Griffin, JD; Hall-Meyers, E; Jiang, J; Kung, AL; McMillin, DW; Mitsiades, C; Moreno, D; Ray, A; Tran, M; Weisberg, E; Wright, RD; Zawel, L | 1 |
1 other study(ies) available for staurosporine and lbw242
Article | Year |
---|---|
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Biomimetic Materials; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; fms-Like Tyrosine Kinase 3; Humans; Inhibitor of Apoptosis Proteins; Leukemia; Mice; Mitochondrial Proteins; Mutant Proteins; Oligopeptides; Staurosporine; Stromal Cells | 2007 |